SCHEMBL5147671

SCHEMBL5147671

CCNC(=O)NCc1cc[c]cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
PPID Q08752 3/20 0.44
EPHX1 P07099 1/20 0.43
PTPN1 P18031 1/20 0.42
NPC1 O15118 3/20 0.42
PPIB P23284 1/20 0.42
PPIA P62937 1/20 0.42
PPIG Q13427 1/20 0.42
ALDH1A1 P00352 3/20 0.41
EPHX2 P34913 1/20 0.41
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144720 0.86 USP2 (0.50) MEN1KMT2ASMN1; SMN2PPIDEPHX1
SCHEMBL970225 0.81 SMN1; SMN2 (0.70) SMN1; SMN2PPIDEPHX1PTPN1NPC1
SCHEMBL27673646 0.79 MEN1 (0.50) MEN1KMT2ASMN1; SMN2EPHX1PTPN1
SCHEMBL754248 0.79 KMT2A (0.58) KMT2ASMN1; SMN2PTPN1NPC1ALDH1A1
SCHEMBL15652114 0.78 PPID (0.65) MEN1KMT2ASMN1; SMN2PPIDEPHX1
SCHEMBL4588276 0.78 MEN1 (0.81) MEN1KMT2ASMN1; SMN2EPHX1NPC1
SCHEMBL14500628 0.78 HTT (0.58) KMT2APPIDEPHX1ALDH1A1MAPT
SCHEMBL12211276 0.78 HPGD (0.58) MEN1KMT2ANPC1ALDH1A1RAB9A
SCHEMBL13317681 0.78 USP2 (0.56) MEN1KMT2ASMN1; SMN2PPIDEPHX1
SCHEMBL16430410 0.76 CYP3A4 (0.61) MEN1KMT2AALDH1A1EPHX2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES IL2, TSLP, IFNG MEN1 4176/4885KMT2A 3086/4885SMN1; SMN2 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.